Company intelligence / Profile preview

RQ Biotechnology Ltd

London W12, London, United Kingdomrqbiotechnology.com ↗
Ownership
Private
Development stage
Other
01

Overview

The first discovered monoclonal antibody by RQ Bio, AZD3152, entered clinical trials within less than a year after discovery as part of AstraZeneca’s SUPERNOVA Phase I/III trial evaluating safety and neutralizing activity against COVID‑19. This rapid progression demonstrates the effectiveness of their antibody discovery platform. Other pipeline programs remain in preclinical stages targeting influenza, CMV, RSV[1][4][8].

Therapeutic areas
Infectious Diseases
Modalities
Monoclonal antibodies (mAbs), broad-spectrum neutralizing antibodiesAntibody therapeutics primarily for passive immunization against viral infections
Industry
Biotech
02

Drug pipeline

2 assets

Long-acting monoclonal antibodies for influenza A (RQ Biotechnology)

Preclinical

1 more asset in the full pipeline.

03

Partnerships

AstraZeneca — exclusive worldwide license agreement for SARS-CoV‑2 mAbs including milestone payments up to $157 million plus royalties[4][6][10]University of Oxford — scientific collaboration and advisory support[4][6]LifeArc — UK medical research charity collaboration supporting development efforts[4][6]

Beyond the preview

Go deeper on RQ Biotechnology Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RQ Biotechnology Ltd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call